Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the study page, signaling a new version of the document. This represents an update or correction to the page content reflected by the new revision number.
    Difference
    0.0%
    Check dated 2026-08-31T17:12:50.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.6.5 updated from v3.6.4, signaling a software update to the page. This change does not appear to modify the study content or displayed information.
    Difference
    0.0%
    Check dated 2026-08-10T11:51:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new internal revision. This appears to be maintenance-only and does not reflect changes to the study information or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-27T06:17:44.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.3, indicating a new version of the page. This reflects a small administrative update to the page without changing the study details.
    Difference
    0.0%
    Check dated 2026-07-05T13:27:39.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:06.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The study page gains new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that enrollment is closed, while the Intervention/Treatment header formatting is updated and the page revision is bumped to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T04:21:02.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.